Lisa Charles

London

Co-Founder and Editor at Choices Magazine-UK

Team Titanium and @choiceslocal Co Founder. Artisitic. Creative. Wife. Mum of 3.

Articles

Human-Readable SBOMs

Nov 1, 2024 | mpo-mag.com | Lisa Charles

I have not seriously dived into the topic of software bill of materials (SBOMs) in this monthly column for several reasons. First, there are numerous SBOM discussions and presentations across the internet. Second, since this is a highly technical topic, it requires more space and graphics than this column permits.
How the Fed’s Interest Rate Decrease Impacts Medtech, M&A, and Fundraising

Nov 1, 2024 | mpo-mag.com | Lisa Charles

In a somewhat unexpected move with positive implications for the medtech industry, the Federal Reserve (Fed) in September opted for a 0.5% interest rate cut. This major policy action was somewhat exciting because it was a more aggressive reduction than the anticipated standard 0.25% adjustment. In the short term, it had a positive impact on the stock market but other factors will determine the longer-term consequences.
Can You Hear Me Now?

Nov 1, 2024 | mpo-mag.com | Lisa Charles

Approximately 15% of American adults over the age of 18 state they have some trouble hearing, and about one-third of the people in the U.S. between the ages of 65 and 74 have hearing loss.
Bring the Beat Back

Nov 1, 2024 | mpo-mag.com | Lisa Charles

Atrial fibrillation (AFib) is an irregular, often very rapid heart rhythm. During AFib, the heart’s atria beat out of sync with its ventricles. Because not enough blood is pumped out of the atria, blood pools in the area, which can clot. The condition increases the risk of stroke, heart failure, and other cardiac complications. For many, AFib has no symptoms. But for some, it can cause a fast, pounding heartbeat, shortness of breath, or light-headedness.
The Risks, Regulations and Innovations of Absorbable Medical Devices

Nov 1, 2024 | mpo-mag.com | Lisa Charles

Synthetic sutures date back to ancient Egypt, when surgeons used plant fibers, hair, tendons, and wool to close patients’ wounds.1 The first synthetic absorbable suture was made from polyvinyl alcohol in 1931.2 There were several other suture-related milestones in the following decades, but the segment took a giant leap forward when U.S. regulators approved an absorbable stent for coronary artery disease in 2016.
Printing Medtech’s Future

Nov 1, 2024 | mpo-mag.com | Lisa Charles

Additive manufacturing/3D printing (AM/3DP) has emerged as a transformative technology in the medical field, revolutionizing various aspects of patient care. By leveraging advanced AM/3DP processes, healthcare professionals can now create highly customized and patient-specific medical solutions, ranging from medical devices to surgical models, with the goal of improving patient outcomes.
Four Recent Developments in Cardiotech

Nov 1, 2024 | mpo-mag.com | Lisa Charles

If you’ve read my feature article in this issue, you already know that pulsed field ablation (PFA) is an exciting and competitive new market in the cardiovascular technology sector. Some of the largest medical device makers are competing for share of the PFA market, with a few smaller companies making it their main mission.
The Future of the Medtech Supply Chain

Nov 1, 2024 | mpo-mag.com | Lisa Charles

Thus far, this century has seen rapid growth and structural changes in the medtech supply chain. This year the industry’s supply chain is expected to generate $85 billion in global revenue, a more than three-fold increase from its $25 billion total in 2000. On paper, that increase translates into a 5.5% compound annual growth rate for 24 consecutive years, but the actual rate has been inconsistent.
Regulatory Approaches to Digital Medical Devicesin the U.K., EU, and U.S.

Oct 31, 2024 | mpo-mag.com | Lisa Charles

New digital technologies are revolutionizing all sectors, including healthcare, with the potential application of artificial intelligence (AI) and machine learning (ML) leading to advancements in diagnostic tools, personalized treatments, sensor-based remote monitoring, and medical data analysis.
What is Revenue Cycle Management?

Feb 1, 2024 | medhealthoutlook.com | Lisa Charles

Revenue cycle management (RCM) refers to managing a healthcare organization’s cash flow, from patient appointment scheduling to account resolution and payment. It encompasses all clinical and financial activities associated with claims submission, reimbursement, denials, appeals, and payment posting. Effectively managing this revenue cycle is critical for healthcare providers to operate efficiently and remain financially viable.